Divalproex Sodium Tablet, Delayed Release
Product Images NDC 55111-531

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 55111-531). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1

FDA Label Image

Carton2

FDA Label Image

Carton3

FDA Label Image

Container1

This looks like the description of a medication. The name of the medication is 'Divalproex Sodium Delayed-Release Tablets USP'. The text also mentions that it's a prescription drug, indicated by 'Rx Only'. There are some alphanumeric codes such as 'Pl SaLoI0Ge', 'RS2 P U]', and 'NDC 55111-529-01' which may represent some unique identifiers for the medicine. The rest of the text seems to be incomplete and unhelpful.*

FDA Label Image

Container2

FDA Label Image

Container3

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Fiigure2 (Figure2)

FDA Label Image

Figure3

This text seems to be a table or a graph showing the reduction in CPS rate in percentage for high dose and low dose treatments. The table further provides the percentage of patients who show improvement, experience no change, or worsen in their condition.*

FDA Label Image

Figure4 (Figure4)

This text suggests that there was a study conducted involving a placebo and a drug called Divalproex sodium. It is not possible to provide further information or context based solely on this text.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.